ExodusPoint Capital Management’s Acadia Pharmaceuticals ACAD Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-76,183	Closed	-$2.03M	–	1502
2025 Q4	$2.03M	Buy	+76,183	New	+$1.82M	0.02%	760
2025 Q2	–	Sell	-37,491	Closed	-$623K	–	1415
2025 Q1	$623K	Sell	37,491 -33,295	-47%	-$605K	0.01%	1061
2024 Q4	$1.3M	Buy	70,786 +11,885	+20%	+$192K	0.01%	858
2024 Q3	$906K	Buy	58,901 +10,816	+22%	+$180K	0.01%	999
2024 Q2	$781K	Sell	48,085 -71,407	-60%	-$1.15M	0.01%	1101
2024 Q1	$2.21M	Buy	+119,492	New	+$2.96M	0.03%	663
2023 Q4	–	Sell	-276,829	Closed	-$5.77M	–	1401
2023 Q3	$5.77M	Buy	+276,829	New	+$7.52M	0.07%	342
2023 Q2	–	Sell	-98,890	Closed	-$1.86M	–	1798
2023 Q1	$1.86M	Sell	98,890 -367,953	-79%	-$7.01M	0.02%	911
2022 Q4	$7.43M	Buy	466,843 +405,846	+665%	+$6.34M	0.11%	242
2022 Q3	$998K	Buy	60,997 +16,224	+36%	+$263K	0.01%	1103
2022 Q2	$631K	Sell	44,773 -28,988	-39%	-$541K	0.01%	1271
2022 Q1	$1.79M	Buy	+73,761	New	+$1.78M	0.03%	838
2021 Q3	–	Sell	-30,188	Closed	-$736K	–	2032
2021 Q2	$736K	Buy	30,188 +4,229	+16%	+$95.5K	0.01%	1161
2021 Q1	$670K	Sell	25,959 -29,597	-53%	-$1.3M	0.01%	1162
2020 Q4	$2.97M	Buy	55,556 +40,844	+278%	+$2.03M	0.05%	400
2020 Q3	$607K	Sell	14,712 -126,294	-90%	-$5.45M	0.02%	914
2020 Q2	$6.83M	Buy	141,006 +132,778	+1,614%	+$6.37M	0.2%	107
2020 Q1	$348K	Sell	8,228 -38,553	-82%	-$1.59M	0.03%	606
2019 Q4	$2M	Buy	+46,781	New	+$2.04M	0.06%	344